HealthQuill Pharma
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation” due to low morale, poor funding and a legitimacy crisis, a UN official said.
Health Medical Pharma

UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief

The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.

Read More
FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing the Anglo-Swedish firm to gain access to an anaemia drug in the world’s most populated nation.
Drugs Health Pharma

AstraZeneca Plc buys China unit of FibroGen Inc for $160 million

HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,.

Read More
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
Health Medical Pharma

Globus Medical Inc to buy US-based Nevro Corp for $250 million all cash

Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.

Read More
Medtronic device recall with loose and cracked systems
Health Pharma

Medtronic’s brain fluid drainage systems face urgent FDA recall

HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recall—the most severe category—for Medtronic’s Becker.

Read More
More than one billion people worldwide are living with obesity and the disease has quadrupled among children and adolescents between five and 19 years of age, according to the World Health Organization.
Health Medical Pharma

Unraveling the link between depression and carbohydrate cravings

Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in.

Read More
Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with hearing loss.
Health Medical Pharma

EssilorLuxottica gets regulator nod for audio glasses in US, EU for hearing loss

Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with.

Read More
Zimmer Biomet Holdings, Inc., a US medical device maker, will acquire Paragon 28 Inc., for $1.1 billion to expand into musculoskeletal care, according to a company statement.
Health Medical Pharma

Zimmer Biomet to buy Paragon 28 for $1.1b to expand musculoskeletal care

Zimmer Biomet Holdings, Inc., a US medical device maker, will acquire Paragon 28 Inc., for $1.1 billion to expand into musculoskeletal care, according.

Read More
A US government’s decision to pause funding for HIV programmes in low and middle-income countries will take the world back to the 1980s and 1990s when millions died of the virus, including many in the United States, according to the World Health Organization.
Drugs Health Pharma

US aid pause to take ‘world back to 1980s, 1990s’ on fighting HIV: WHO 

A US government’s decision to pause funding for HIV programmes in low and middle-income countries will take the world back to the 1980s.

Read More
Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug regulator in the adult population. 
Drugs Health Pharma

AstraZeneca-Daiichi’s breast cancer drug gets broader US nod

Anglo-Swedish AstraZeneca Plc., and Japan’s Daiichi Sankyo’s therapy to treat a certain form of breast cancer has been approved by the US drug.

Read More